TransGenic Group (2342.T) Stock Price
TransGenic Group Price
Revenue has compounded at 19.7% per year over the past 19 years to 13.17 B JPY. Earnings per share have declined at 15.8% per year over the last 11 years. TransGenic Group's net margin stands at -0.6%, down from 14.9% several years earlier. TransGenic Group currently offers a dividend yield of about 1.33%.
TransGenic Group stock price
Access this data via the Eulerpool API
100,000 free requests/mo · no credit card
TransGenic Group business model & stock analysis
Frequently asked questions about TransGenic Group
Converted at the current exchange rate, the TransGenic Group share trades at 1.27 EUR (226.00 JPY).
The revenue of TransGenic Group is 13.17 B JPY. This figure is based on current financial data and reflects the company's business performance.
The profit of TransGenic Group is -77.27 M JPY. The net profit reflects the company's profitability after deducting all expenses.
The price-to-earnings ratio (P/E) of TransGenic Group is currently -48.71. The P/E ratio compares the current share price to the earnings per share and helps investors assess the valuation of the TransGenic Group stock.
The price-to-sales ratio (P/S) of TransGenic Group is currently 0.29. The P/S ratio compares the market capitalization to the annual revenue and serves as a valuation metric for the TransGenic Group stock.
The Eulerpool Quality Score for TransGenic Group is 4/10.
The ISIN of TransGenic Group is JP3635720000. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.
The ticker of TransGenic Group is 2342.T. The ticker symbol is used to trade TransGenic Group shares on the stock exchange.
TransGenic Group stock
TransGenic Group Peer Group
TransGenic Group FIGI
All fundamentals and in-depth analysis of TransGenic Group
Our stock analysis for TransGenic Group stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of TransGenic Group. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.